Drug intelligence / Profile preview

soybean extract

Development stage
Unknown
Lead developer
Universidade de São Paulo
Administration
Oral, Topical
01

Overview

Soybean extract is a botanical product derived from the seeds of the soybean plant (*Glycine max*). It contains a variety of bioactive compounds, including isoflavones such as genistein and daidzein, as well as proteins, saponins, and peptides. In therapeutic research, particularly oncology, biotransformed soybean extract (BSE)—often produced through fermentation by fungi like *Aspergillus awamori*—has demonstrated enhanced antiproliferative and proapoptotic properties compared to non-biotransformed versions. BSE has been shown to inhibit the growth of melanoma cells by activating the extrinsic apoptotic pathway, characterized by the induction of PARP cleavage, activation of caspases-3, -7, and -8, and the upregulation of TRAIL and its receptor DR4. Additionally, it may modulate NFκB signaling to facilitate cell death. Beyond oncology, soybean extracts are widely studied for their effects on menopausal symptoms, bone health, and lipid metabolism.

Other names
Glycine max extractbiotransformed soybean extractfermented soybean extract
02

Targets

CASP7 (Caspase-7)TNFRSF10A (Death receptor 4)NF-κBCASP3 (Caspase-3)CASP8 (Caspase-8)

Beyond the preview

Go deeper on soybean extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on soybean extract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call